Journal of Peking University (Health Sciences) ›› 2023, Vol. 55 ›› Issue (6): 1130-1134. doi: 10.19723/j.issn.1671-167X.2023.06.027

Previous Articles     Next Articles

Sjögren's syndrome combined with cold agglutinin disease: A case report

Li-fang WANG1,Lian-jie SHI1,Wu NING2,Nai-shu GAO3,Kuan-ting WANG1,*()   

  1. 1. Department of Rheumatology and Immunology, Peking University Shougang Hospital, Beijing 100144, China
    2. Departmem of Infectious Disease, Peking University Shougang Hospital, Beijing 100144, China
    3. Depanment of Clinical Laboratory, Peking University Shougang Hospital, Beijing 100144, China
  • Received:2023-08-02 Online:2023-12-18 Published:2023-12-11
  • Contact: Kuan-ting WANG E-mail:kuantingwang@163.com

RICH HTML

  

Abstract:

Sjögren's syndrome(SS)is a chronic autoimmune disease that affects exocrine glands, especially salivary and lacrimal glands. The main clinical manifestations are dry mouth and dry eyes, but also multi-organ and multi-system can be involved. Cold agglutinin disease(CAD)is an autoimmune disease characterized by red blood cell agglutination in the blood vessels of extremities caused by cold agglutinin at low temperature, resulting in skin microcirculation disturbance, or hemolytic anemia. Cold agglutinin disease is divided into two categories, primary cold agglutinin disease and secondary cold agglutinin disease. Primary cold agglutinin disease is characterized with cold agglutinin titer of 1 ∶4 000 or more and positive Coomb's test. However, the Coomb's test is not necessarily positive and the cold agglutinin titer is between 1 ∶32 and 1 ∶4 000 in secondary cold agglutinin disease. Here, we reported an elderly patient admitted to hospital due to fever. He was diagnosed with respiratory infection, but he showed incompletely response to the anti-infection treatment. Further laboratory tests showed the patient with positive ANA and anti-SSA antibodies. Additionally, the patient complained that he had dry mouth and dry eyes for 1 year. Schirmer test and salivate gland imaging finally confirmed the diagnosis Sjogren's syndrome. During the hospital stay, the blood clots were found in the anticoagulant tubes. Hemolytic anemia was considered as the patient had anemia with elevated reticulocytes and indirect bilirubin. In addition, further examination showed positive cold agglutination test with a titer of 1 ∶1 024, and cold agglutinin disease was an important type of cold-resistant autoimmune hemolytic anemia. Furthermore, the patient developed cyanosis after ice incubating at the tip of the nose. Hence, the patient was diagnosed as CAD and he was successfully treated with glucocorticoids instead of anti-infection treatments. Hence, the patient was diagnosed with SS combined with secondary CAD. SS combined CAD are rarely reported, and they are both autoimmune diseases. The abnormal function of B lymphocytes and the production of autoantibodies might be the common pathogenesis of them. Cold agglutinin disease can lead to severe hemolytic anemia, even life-threatening. In clinical practice, timely recognizing and dealing with CAD might promote the prognosis of the patient.

Key words: Sjögren's syndrome, Cold agglutinin, Infection, Glucocorticoid

CLC Number: 

  • R593.2

Figure 1

Chest CT scan showed no obvious spots and effusion"

Figure 2

Blood clots was developed in the anticoagulant tubes (A); After incubating in a 37 ℃ incubator, the clots lysed (B)"

Figure 3

The patient developed cyanosis at the tip of the nose after 1 minute of ice incubation(A), nasal tip cyanosis disappeared after the ice removed (B)"

1 Berentsen S . How I manage patients with cold agglutinin disease[J]. Br J Haematol, 2018, 181 (3): 320- 330.
doi: 10.1111/bjh.15109
2 Berentsen S , Ulvestad E , Langholm R , et al. Primary chronic cold agglutinin disease: A population based clinical study of 86 patients[J]. Haematologica, 2006, 91 (4): 460- 466.
3 Broome C M . Diagnosis and treatment of cold agglutinin disease[J]. Clin Adv Hematol Oncol, 2019, 17 (3): 162- 165.
4 刘京倩, 张凤奎. 冷凝集素疾病的诊疗进展[J]. 中华血液学杂志, 2022, 43 (6): 524- 528.
5 Berentsen S . New insights in the pathogenesis and therapy of cold agglutinin-mediated autoimmune hemolytic anemia[J]. Front Immunol, 2020, 11, 590.
doi: 10.3389/fimmu.2020.00590
6 Kikuchi M , Inagaki T . A case of primary Sjögren's syndrome associated with low titer cold agglutinin disease[J]. Clin Exp Rheumatol, 2002, 20 (4): 577- 578.
7 Bouaziz J D , Yanaba K , Tedder T F . Regulatory B cells as inhibitors of immune responses and inflammation[J]. Immunol Rev, 2008, 224 (1): 201- 214.
doi: 10.1111/j.1600-065X.2008.00661.x
8 蔡丽敏, 陈志强. B细胞活化因子与干燥综合征[J]. 国际皮肤性病学杂志, 2007, 33 (2): 95- 97.
9 王琳, 张文, 李梦涛, 等. 原发性干燥综合征患者及其一级亲属外周血记忆性B细胞、B细胞激活因子及与临床指标的相关性[J]. 协和医学杂志, 2010, 1 (2): 132- 136.
10 Berentsen S , Malecka A , Randen U , et al. Cold agglutinin disease: Where do we stand, and where are we going?[J]. Clin Adv Hematol Oncol, 2020, 18 (1): 35- 44.
11 Hill QA , Stamps R , Massey E , et al. The diagnosis and management of primary autoimmune haemolytic anaemia[J]. Br J Haematol, 2017, 176 (3): 395- 411.
doi: 10.1111/bjh.14478
12 Rossi G , Gramegna D , Paoloni F , et al. Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: A phase 2 prospective GIMEMA study[J]. Blood, 2018, 132 (5): 547- 550.
doi: 10.1182/blood-2018-03-835413
13 Zaninoni A , Giannotta J A , Gallì A , et al. The immunomodula-tory effect and clinical efficacy of daratumumab in a patient with cold agglutinin disease[J]. Front Immunol, 2021, 12, 649441.
doi: 10.3389/fimmu.2021.649441
14 Jäger U , D'Sa S , Schörgenhofer C , et al. Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: A first-in-human trial[J]. Blood, 2019, 133 (9): 893- 901.
15 Röth A , Bommer M , Hüttmann A , et al. Eculizumab in cold agglutinin disease (DECADE): An open-label, prospective, bicentric, nonrandomized phase 2 trial[J]. Blood Adv, 2018, 2 (19): 2543- 2549.
16 Kotani T , Takeuchi T , Kawasaki Y , et al. Successful treatment of cold agglutinin disease with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus[J]. Lupus, 2006, 15 (10): 683- 685.
17 Malesci D , La Montagna G . Occurrence of cold agglutinin disease in RA patient during etanercept therapy successfully treated with rituximab[J]. Rheumatology (Oxford), 2008, 47 (5): 734- 735.
[1] Xiaomeng REN,Kaiyi LI,Chunlei LI. Detection of molecular affecting sensitivity to local glucocorticoid therapy in oral lichen planus through transcriptome sequencing [J]. Journal of Peking University (Health Sciences), 2024, 56(1): 32-38.
[2] Jie QIAO,Li-xia LU,Yu-ting HE,Chun-cui MEN,Xin-xin CHU,Bei WU,Hui-ping ZHAO,Mei WANG. Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 748-754.
[3] Hao LIN,Jing-hua LI,Xiao YANG,Xiao-ting CHEN,Yu-hui SHI,Chun CHANG,Yuan-tao HAO,Wang-nan CAO. Discrepancy between behavioral-indicated and perceived candidacy for HIV pre-exposure prophylaxis among men who have sex with men in Chengdu, China [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 511-520.
[4] Zhe WANG,Wei SUN,Xue YANG,Ying SONG,Ai-ping JI,Jie BAI. Clinical analysis of patients with oral and maxillofacial infections in oral emergency [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 543-547.
[5] Yi-lin YE,Heng LIU,Li-ping PAN,Wei-bing CHAI. Periprosthetic gout flare after total knee arthroplasty: A misdiagnostic case report [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 362-365.
[6] Fang CAO,Ming ZHONG,Cong-rong LIU. Uterine POLE mutant endometrioid carcinoma combined with human papilloma virus-associated cervical adenocarcinoma: A case report and literature review [J]. Journal of Peking University (Health Sciences), 2023, 55(2): 370-374.
[7] Xiao-yan XING,Jun-xiao ZHANG,Feng-yun-zhi ZHU,Yi-fan WANG,Xin-yao ZHOU,Yu-hui LI. Clinical analysis of 5 cases of dermatomyositis complicated with macrophage activation syndrome [J]. Journal of Peking University (Health Sciences), 2022, 54(6): 1214-1218.
[8] Le-qing CAO,Jing-rui ZHOU,Yu-hong CHEN,Huan CHEN,Wei HAN,Yao CHEN,Yuan-yuan ZHANG,Chen-hua YAN,Yi-fei CHENG,Xiao-dong MO,Hai-xia FU,Ting-ting HAN,Meng LV,Jun KONG,Yu-qian SUN,Yu WANG,Lan-ping XU,Xiao-hui ZHANG,Xiao-jun HUANG. Relationship between treatment and prognosis in patients with late-onset severe pneumonia after allogeneic hematopoietic stem cell transplantation [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 1013-1020.
[9] Zhi-yu KANG,Lei-lei WANG,Yong-zheng HAN,Xiang-yang GUO. Anesthesia management of athletes' operation in Beijing Olympic Winter Games [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 770-773.
[10] ZHANG Pu-li,YANG Hong-xia,ZHANG Li-ning,GE Yong-peng,PENG Qing-lin,WANG Guo-chun,LU Xin. Value of serum YKL-40 in the diagnosis of anti-MDA5-positive patients with dermatomyositis complicated with severe pulmonary injury [J]. Journal of Peking University (Health Sciences), 2021, 53(6): 1055-1060.
[11] Hong MENG,Li-na JI,Jing HUANG,Shuang CHAO,Jia-wen ZHOU,Xue-jun LI,Xiao-mei YIN,Li-rong FAN. Analysis of the changes and characteristics of pediatric outpatient visits in a general hospital in Beijing before and after the COVID-19 pandemic [J]. Journal of Peking University (Health Sciences), 2021, 53(5): 952-956.
[12] DU Qiang,HONG Kai,PAN Bo-chen. Comparison of two methods for detection of Chlamydia trachomatis and Ureaplasma urealyticum in male reproductive tract [J]. Journal of Peking University (Health Sciences), 2021, 53(4): 785-788.
[13] ZHOU Bo-lin,LI Wei-shi,SUN Chui-guo,QI Qiang,CHEN Zhong-qiang,ZENG Yan. Risk factors for multiple debridements of the patients with deep incisional surgical site infection after spinal surgery [J]. Journal of Peking University (Health Sciences), 2021, 53(2): 286-292.
[14] YUAN Yuan,LANG Ning,YUAN Hui-shu. CT spectral curve in differentiating spinal tumor metastasis and infections [J]. Journal of Peking University (Health Sciences), 2021, 53(1): 183-187.
[15] Shi-bo LIU,Hui GAO,Yuan-chun FENG,Jing LI,Tong ZHANG,Li WAN,Yan-ying LIU,Sheng-guang LI,Cheng-hua LUO,Xue-wu ZHANG. Clinical features of hydronephrosis induced by retroperitoneal fibrosis: 17 cases reports [J]. Journal of Peking University (Health Sciences), 2020, 52(6): 1069-1074.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] . [J]. Journal of Peking University(Health Sciences), 2007, 39(3): 225 -328 .
[2] . [J]. Journal of Peking University(Health Sciences), 2007, 39(5): 498 -502 .
[3] . [J]. Journal of Peking University(Health Sciences), 2000, 32(4): 383 .
[4] . [J]. Journal of Peking University(Health Sciences), 2000, 32(4): 300 .
[5] . [J]. Journal of Peking University(Health Sciences), 2001, 33(6): 565 .
[6] . [J]. Journal of Peking University(Health Sciences), 2008, 40(1): 39 -42 .
[7] . [J]. Journal of Peking University(Health Sciences), 2008, 40(6): 600 -602 .
[8] . [J]. Journal of Peking University(Health Sciences), 2009, 41(5): 537 -540 .
[9] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 90 -94 .
[10] . [J]. Journal of Peking University(Health Sciences), 2003, 35(4): 382 -385 .